EUCTR2015-002678-19-IT进行中（未招募）1 期
Clinical Evaluation of Metal Panel Allergens: Aluminum, Copper, Manganese, Molybdenum, Tin, Titanium, Vanadium and Zinc Dose Response Study - Metal Allergen Dose Response Patch Test
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 122
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) 18 years of age or older.
- •2) Past positive patch test result within the past 10 years (to one of the dilution series metals being tested on this study) or strong suspicion of metal contact allergy based on results of the Qualification Questionnaire.
- •3) Unable to become pregnant or willing to use an acceptable method of contraception to prevent pregnancy if female of childbearing potential (Inability to become pregnant would include all male subjects and female subjects who are postmenopausal for at least 1 year, or surgically sterile- have had a hysterectomy, bilateral ovariectomy, uterine ablation or bilateral tubal ligation. Acceptable methods of contraception include: 1) systemic birth control; 2) double barrier method; 3) IUD; 4) vasectomized partner; or 5) abstinence from sexual intercourse. Subject must agree to use acceptable contraception for the duration of the entire study.)
- •4) Understands and signs the approved Informed Consent form which is consistent with all institutional, local and national regulations.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 350
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •1) Breastfeeding or pregnant (as determined by urine pregnancy test) or intending to become pregnant during the course of the study.
- •2) Topical treatment with corticosteroids or other immunosuppressive agents on or near the test area during the 14 days prior to inclusion through the end of this study.
- •3) Systemic treatment with corticosteroids (equivalent to > 10 mg prednisone) or other immunosuppressive agents 14 days prior to inclusion through the end of the subject’s participation in the study. Inhaled treatments and steroidal nose or eye drops are permitted.
- •4) Treatment with ultraviolet (UV) light (including tanning) during the 3 weeks prior to inclusion through the end of this study.
- •5) Acute dermatitis outbreak or dermatitis on or near the test area on the back.
- •6) Known or suspected infection of the skin, joints or other site(s) associated with metal exposure
- •7) Conditions such as; fibromyalgia, chronic fatigue, depression, cognitive impairment, flu-like symptoms, diarrhea and/or headache without at least one of the symptoms related to metal exposure listed in Section 10.1 under physical examination
- •8) A condition such as; psoriasis, dermatitis herpetiformis, mycosis fungoides or cutaneous T-cell lymphoma that may confound the evaluation of allergic contact dermatitis.
- •9) Inability to comply with patch test study requirements including multiple return visits and activity restrictions (e.g., protecting test panels from excess moisture due to showering or vigorous activity).
- •10) Participation in a clinical trial of an investigational drug, treatment or device during this study or 3 weeks prior to inclusion in this study.
- •11) An opinion of the Investigator that deems the potential subject to be non-compliant, unable to return for study visits or complete the study as detailed in the protocol.
研究者
相似试验
进行中（未招募）
1 期
8 Metal Dose Response StudyMetal induced contact dermatitisMedDRA version: 19.0Level: SOCClassification code 10040785Term: Skin and subcutaneous tissue disordersSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2015-002678-19-DESmartPractice400
进行中（未招募）
1 期
Metal Allergen Patch TestDiagnosis of Allergic Contact DermatitisMedDRA version: 20.0Level: SOCClassification code 10021428Term: Immune system disordersSystem Organ Class: 10021428 - Immune system disordersEUCTR2012-005459-18-ITSMARTPRACTICE60
进行中（未招募）
1 期
Metal Panel Patch TestCTIS2023-507972-35-00Smarthealth Inc.300
尚未招募
3 期
Metal Panel Patch Test StudySkin rash, EczemaD000066491JPRN-jRCT2031220654Yoshizumi Yuriko300
进行中（未招募）
1 期
Metal Panel Patch TestAllergic contact dermatitisCTIS2023-507972-35-01Smarthealth Inc.290